SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.
about
Comparative in vitro evaluation of cefonicid, cefazolin, and penicillin against viridans group streptococci isolated from blood.Pharmacokinetics of new broad-spectrum cephamycin, YM09330, parenterally administered to various experimental animalsPharmacokinetics of the cephalosporin SM-1652 in mice, rats, rabbits, dogs, and rhesus monkeys.Clinical trial of cefonicid for treatment of skin infections.Evaluation of the cefonicid disk test criteria, including disk quality control guidelinesEffect of age and renal function on cefonicid pharmacokineticsPeritoneal transport of cefonicid.Azlocillin and cefonicid penetration into bone enhanced by probenecid.Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics.Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporinCefonicid versus clindamycin prophylaxis for head and neck surgery in a randomized, double-blind trial, with pharmacokinetic implications.Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects.Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.
P2860
Q35574711-7C352739-E4B2-449D-B7A2-49ECA8CB2729Q35671131-40EEE576-1DCD-4FFA-A986-E09F708FCAC8Q35714346-863E6A53-2DA4-489B-9794-CCA8743A475EQ35745761-CD12224A-AC9F-4D03-8364-E04A8084A349Q37303343-2F858522-941B-496F-A8FF-C06A6A7500D7Q39814883-6AC41D60-0026-4AD4-B20C-6EAF06287BB7Q39827692-6381B70D-4CBF-466E-808B-A29DC1321C2EQ39833430-992736CA-B5CD-4F59-BD5B-ABCB72698881Q39835731-BCAB87C2-054E-4261-8384-D383E3BC8430Q39850768-3A8BB828-DD16-443E-A8AE-F54A33405F10Q39850906-D40D5C1D-4EBF-4DA8-9AAB-C748850AB398Q39857241-D790E1D2-3606-4549-95C3-E13D9D2AB97AQ40086773-5A5393BE-48F4-4DCA-A9E3-10557FEB1103Q40197702-5C71D98C-B1F6-4097-88B8-EEF34CADD2D7Q40621581-BED64087-A89F-45BD-BD7E-3BFF6A02D216
P2860
SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
SK&F 75073, new parenteral bro ...... gh and prolonged serum levels.
@ast
SK&F 75073, new parenteral bro ...... gh and prolonged serum levels.
@en
type
label
SK&F 75073, new parenteral bro ...... gh and prolonged serum levels.
@ast
SK&F 75073, new parenteral bro ...... gh and prolonged serum levels.
@en
prefLabel
SK&F 75073, new parenteral bro ...... gh and prolonged serum levels.
@ast
SK&F 75073, new parenteral bro ...... gh and prolonged serum levels.
@en
P2093
P2860
P356
P1476
SK&F 75073, new parenteral bro ...... gh and prolonged serum levels.
@en
P2093
Guarini JR
Phillips L
Weisbach JA
P2860
P304
P356
10.1128/AAC.13.5.784
P407
P577
1978-05-01T00:00:00Z